Deutsche Bank analyst Brad Zelnick raised the firm’s price target on Cellebrite (CLBT) to $27 from $24 and keeps a Buy rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLBT:
- Lake Street raises Cellebrite price target, sees pullback as buying opportunity
- Cellebrite price target raised to $30 from $25 at TD Cowen
- Cellebrite Reports Strong Growth in 2024 Earnings
- Strategic Initiatives and Long-term Growth Drive Buy Rating for Cellebrite DI
- Cellebrite Achieves Strong 2024 Financial Performance with Significant ARR Growth
Questions or Comments about the article? Write to editor@tipranks.com